This subgroup furthermore displayed a pronounced upregulation of cellular metabolic pathways, which we also observed in pulmonary carcinoids (Fig. 2b), but which was less prominent in LCNECs and SCLC tumors with RB1 alterations (Fig. 3a, b, Supplementary Data 12–13). This evidence concerns the gene RB1 and small cell lung carcinoma.